206 related articles for article (PubMed ID: 31027181)
1. Role of Dusp6 Phosphatase as a Tumor Suppressor in Non-Small Cell Lung Cancer.
Moncho-Amor V; Pintado-Berninches L; Ibañez de Cáceres I; Martín-Villar E; Quintanilla M; Chakravarty P; Cortes-Sempere M; Fernández-Varas B; Rodriguez-Antolín C; de Castro J; Sastre L; Perona R
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31027181
[TBL] [Abstract][Full Text] [Related]
2. Tumor suppressor dual-specificity phosphatase 6 (DUSP6) impairs cell invasion and epithelial-mesenchymal transition (EMT)-associated phenotype.
Wong VC; Chen H; Ko JM; Chan KW; Chan YP; Law S; Chua D; Kwong DL; Lung HL; Srivastava G; Tang JC; Tsao SW; Zabarovsky ER; Stanbridge EJ; Lung ML
Int J Cancer; 2012 Jan; 130(1):83-95. PubMed ID: 21387288
[TBL] [Abstract][Full Text] [Related]
3. Tripartite motif protein 11 (TRIM11), an oncogene for human lung cancer via the DUSP6-mediated ERK1/2 signaling pathway.
Wang XL; Lu SC; Sun C; Jin WG; Fan YW; Shu YS; Shi HC; Min LF
Cancer Biol Ther; 2021 Apr; 22(4):324-332. PubMed ID: 33970779
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of DUSP6 with expression of ERK and Ki-67 in non-small cell lung carcinoma.
Lee H; Kim JM; Huang SM; Park SK; Kim DH; Kim DH; Lee CS; Suh KS; Yi ES; Kim KH
Pathol Res Pract; 2011 Jul; 207(7):428-32. PubMed ID: 21680106
[TBL] [Abstract][Full Text] [Related]
5. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of dual-specificity phosphatase 6 expression in non-small cell lung cancer.
Díaz-García CV; Agudo-López A; Pérez C; Prieto-García E; Iglesias L; Ponce S; Rodríguez Garzotto A; Rodríguez-Peralto JL; Cortés-Funes H; López-Martín JA; Agulló-Ortuño MT
Tumour Biol; 2015 Feb; 36(2):1199-206. PubMed ID: 25344212
[TBL] [Abstract][Full Text] [Related]
7. Dual-specificity phosphatase 6 plays a critical role in the maintenance of a cancer stem-like cell phenotype in human endometrial cancer.
Kato M; Onoyama I; Yoshida S; Cui L; Kawamura K; Kodama K; Hori E; Matsumura Y; Yagi H; Asanoma K; Yahata H; Itakura A; Takeda S; Kato K
Int J Cancer; 2020 Oct; 147(7):1987-1999. PubMed ID: 32159851
[TBL] [Abstract][Full Text] [Related]
8. Association of Topoisomerase II (TOP2A) and Dual-Specificity Phosphatase 6 (DUSP6) Single Nucleotide Polymorphisms with Radiation Treatment Response and Prognosis of Lung Cancer in Han Chinese.
Wang TL; Ren YW; Wang HT; Yu H; Zhao YX
Med Sci Monit; 2017 Feb; 23():984-993. PubMed ID: 28231233
[TBL] [Abstract][Full Text] [Related]
9. Rab8 GTPase regulates Klotho-mediated inhibition of cell growth and progression by directly modulating its surface expression in human non-small cell lung cancer.
Chen B; Huang S; Pisanic Ii TR; Stark A; Tao Y; Cheng B; Li Y; Wei Y; Zhao W; Wang TH; Wu J
EBioMedicine; 2019 Nov; 49():118-132. PubMed ID: 31707148
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of IL-11, an IL-6 Family Cytokine, Promotes Tumor Progression and Correlates with Poor Prognosis in Non-Small Cell Lung Cancer.
Zhao M; Liu Y; Liu R; Qi J; Hou Y; Chang J; Ren L
Cell Physiol Biochem; 2018; 45(6):2213-2224. PubMed ID: 29550807
[TBL] [Abstract][Full Text] [Related]
11. Zyxin is a transforming growth factor-β (TGF-β)/Smad3 target gene that regulates lung cancer cell motility via integrin α5β1.
Mise N; Savai R; Yu H; Schwarz J; Kaminski N; Eickelberg O
J Biol Chem; 2012 Sep; 287(37):31393-405. PubMed ID: 22778267
[TBL] [Abstract][Full Text] [Related]
12. EGFR inhibition evokes innate drug resistance in lung cancer cells by preventing Akt activity and thus inactivating Ets-1 function.
Phuchareon J; McCormick F; Eisele DW; Tetsu O
Proc Natl Acad Sci U S A; 2015 Jul; 112(29):E3855-63. PubMed ID: 26150526
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-3127-5p promotes epithelial-mesenchymal transition via FZD4 regulation of Wnt/β-catenin signaling in non-small-cell lung cancer.
Yang Y; Sun Y; Wu Y; Tang D; Ding X; Xu W; Su B; Gao W
Mol Carcinog; 2018 Jul; 57(7):842-853. PubMed ID: 29566281
[TBL] [Abstract][Full Text] [Related]
14. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells.
Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG
Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790
[TBL] [Abstract][Full Text] [Related]
15. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
16. Dual Specificity Phosphatase 6 (DUSP6) Polymorphism Predicts Prognosis of Inoperable Non-Small Cell Lung Cancer after Chemoradiotherapy.
Wang TL; Song YQ; Ren YW; Zhou BS; Wang HT; Bai L; Zhang HB; Yu H; Zhao YX
Clin Lab; 2016; 62(3):301-10. PubMed ID: 27156317
[TBL] [Abstract][Full Text] [Related]
17. Dual specificity phosphatase 6 (DUSP6) is an ETS-regulated negative feedback mediator of oncogenic ERK signaling in lung cancer cells.
Zhang Z; Kobayashi S; Borczuk AC; Leidner RS; Laframboise T; Levine AD; Halmos B
Carcinogenesis; 2010 Apr; 31(4):577-86. PubMed ID: 20097731
[TBL] [Abstract][Full Text] [Related]
18. Phosphatase of regenerating liver-3 inhibits invasiveness and proliferation in non-small cell lung cancer by regulating the epithelial-mesenchymal transition.
Lin SY; Lee YX; Yu SL; Chang GC; Chen JJ
Oncotarget; 2016 Apr; 7(16):21799-811. PubMed ID: 26967563
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of DUSP6 expression in lung cancer: its mechanism and potential role in carcinogenesis.
Okudela K; Yazawa T; Woo T; Sakaeda M; Ishii J; Mitsui H; Shimoyamada H; Sato H; Tajiri M; Ogawa N; Masuda M; Takahashi T; Sugimura H; Kitamura H
Am J Pathol; 2009 Aug; 175(2):867-81. PubMed ID: 19608870
[TBL] [Abstract][Full Text] [Related]
20. Dual-specificity phosphatase 6 (Dusp6), a negative regulator of FGF2/ERK1/2 signaling, enhances 17β-estradiol-induced cell growth in endometrial adenocarcinoma cell.
Zhang H; Guo Q; Wang C; Yan L; Fu Y; Fan M; Zhao X; Li M
Mol Cell Endocrinol; 2013 Aug; 376(1-2):60-9. PubMed ID: 23419500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]